NO940972L - Nye - Google Patents

Nye

Info

Publication number
NO940972L
NO940972L NO940972A NO940972A NO940972L NO 940972 L NO940972 L NO 940972L NO 940972 A NO940972 A NO 940972A NO 940972 A NO940972 A NO 940972A NO 940972 L NO940972 L NO 940972L
Authority
NO
Norway
Prior art keywords
alpha
beta
pyrindine
tetrols
octahydro
Prior art date
Application number
NO940972A
Other languages
English (en)
Other versions
NO300372B1 (no
NO940972D0 (no
Inventor
Robert A Farr
Mohinder Singh Kang
Norton Paul Peet
Sai Prasad Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO940972D0 publication Critical patent/NO940972D0/no
Publication of NO940972L publication Critical patent/NO940972L/no
Publication of NO300372B1 publication Critical patent/NO300372B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
NO940972A 1991-09-18 1994-03-17 Nye <alfa>-mannosidaseinhibitorer NO300372B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76157991A 1991-09-18 1991-09-18
US07/893,171 US5262425A (en) 1991-09-18 1992-06-03 α-mannosidase inhibitors
PCT/US1992/006707 WO1993005781A1 (en) 1991-09-18 1992-08-10 Novel alpha-mannosidase inhibitors

Publications (3)

Publication Number Publication Date
NO940972D0 NO940972D0 (no) 1994-03-17
NO940972L true NO940972L (no) 1994-03-17
NO300372B1 NO300372B1 (no) 1997-05-20

Family

ID=27117010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940972A NO300372B1 (no) 1991-09-18 1994-03-17 Nye <alfa>-mannosidaseinhibitorer

Country Status (15)

Country Link
US (1) US5262425A (no)
EP (1) EP0641327B1 (no)
JP (1) JP3226173B2 (no)
KR (1) KR100244012B1 (no)
AT (1) ATE175960T1 (no)
AU (1) AU659486B2 (no)
CA (1) CA2116224C (no)
DE (1) DE69228259T2 (no)
DK (1) DK0641327T3 (no)
ES (1) ES2127758T3 (no)
FI (1) FI105270B (no)
GR (1) GR3029745T3 (no)
HU (1) HU216789B (no)
NO (1) NO300372B1 (no)
WO (1) WO1993005781A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
AU736668B2 (en) * 1996-10-01 2001-08-02 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US6245316B1 (en) 1997-10-08 2001-06-12 David Platt Enhancement of delivery of radioimaging and radioprotective agents
EP1023290A1 (en) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031102A (en) * 1972-10-21 1977-06-21 John Wyeth & Brother Limited Cyclopenteno[b]pyridine derivatives
GB2088860B (en) * 1980-12-09 1984-05-23 Wyeth John & Brother Ltd Process for preparing ring-fused pyridine derivatives

Also Published As

Publication number Publication date
WO1993005781A1 (en) 1993-04-01
HU216789B (hu) 1999-08-30
EP0641327B1 (en) 1999-01-20
EP0641327A4 (en) 1994-06-01
KR100244012B1 (ko) 2000-03-02
GR3029745T3 (en) 1999-06-30
US5262425A (en) 1993-11-16
NO300372B1 (no) 1997-05-20
ATE175960T1 (de) 1999-02-15
AU659486B2 (en) 1995-05-18
DE69228259T2 (de) 1999-06-02
HUT70527A (en) 1995-10-30
JPH06510785A (ja) 1994-12-01
NO940972D0 (no) 1994-03-17
AU2477192A (en) 1993-04-27
DK0641327T3 (da) 1999-09-13
JP3226173B2 (ja) 2001-11-05
FI941259A (fi) 1994-03-17
FI105270B (fi) 2000-07-14
CA2116224C (en) 2003-06-03
FI941259A0 (fi) 1994-03-17
CA2116224A1 (en) 1993-04-01
EP0641327A1 (en) 1995-03-08
DE69228259D1 (de) 1999-03-04
ES2127758T3 (es) 1999-05-01
HU9400787D0 (en) 1994-06-28

Similar Documents

Publication Publication Date Title
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
NO944430D0 (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
CO4290353A1 (es) Agonistas de estrogeno
BR9203707A (pt) Compostos,composicao,emprego de compostos,processo para a fotopolimerizacao de compostos e emprego de uma composicao
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
ES2117034T3 (es) Composicion para la limpieza de vidrio.
DE69516866D1 (de) Stereochemische wortmanninderivate
NO914092L (no) Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace
PT92146A (pt) Processo para a preparacao do inibidor de glicosidade salbostatina e de composicoes farmaceuticas que a contem
NO925041D0 (no) Nye 2-sakkarinylmetylaryl- og aryloksyacetater som er nyttige som proteolytiske enzymerinhibitorer
NO932547L (no) Isoksazolederivater for behandling av irritabelt tarmsyndrom
KR950704257A (ko) 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors)
NO940972L (no) Nye
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
ES2060405T3 (es) Derivado de la melatonina que tiene actividad terapeutica en dermatologia.
ATE78988T1 (de) Verfahren zum steigern der produktivitaet in mutterschweinen.
HUT60994A (en) Process for producing 2,3,4-trihydroxy-5-(hydroxymethyl)-cyclopentyl amine derivatives
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
PT94011A (pt) Processo para a preparacao de 8 alfa- acilamino-ergolinas e de composicoes farmaceuticas que as contem
MX9305453A (es) Metodo para tratar infecciones virales.
FI922016A0 (fi) Foerfarande foer framstaellning av dubbelskyddade 1-karba(1-detia)-3-kefem-4-karboxylsyror.
IT1231065B (it) Dispositivo per eseguire l&#39;asportazione chirurgica di segmenti di organi, per esempio segmenti epatici.
ITRM940151A0 (it) Impiego di esteruretani per la riconcia.
ITMI931684A0 (it) Procedimento per la preparazione di derivati del 5,4- diidrocarbostirile